Firma Clinical Research
Generated 5/9/2026
Executive Summary
Firma Clinical Research is a privately-held, independent provider of home trial services and expert biostatistics, founded in 2005 and headquartered in Wilmington, DE. The company positions itself as a flexible and integrity-driven partner for biopharma sponsors developing novel therapies. By offering decentralized clinical trial solutions—including home-based patient visits, remote monitoring, and comprehensive biostatistical analysis—Firma addresses the growing demand for patient-centric, cost-effective drug development. Its niche specialization in home trial services differentiates it from larger, full-service CROs, allowing nimble execution for small to mid-size sponsors. With the clinical research outsourcing market expanding, Firma is well-poised to capture increased demand for decentralized trial capabilities and statistical expertise.
Upcoming Catalysts (preview)
- Q4 2026Expansion of Home Trial Services into Rare Disease & Oncology60% success
- Q1 2027Launch of AI-Enhanced Biostatistics Platform50% success
- Q2 2027Potential Partnership or Acquisition by Larger CRO Seeking Decentralized Capabilities40% success
- · Pipeline Analysis
- · Competitive Landscape
- · Catalyst Calendar (full 12-month)
- · Bull Case
- · Bear Case
- · Counterfactual Scenarios
- · Valuation Notes
- · SEC Filing Highlights
- · Insider Activity
- · Literature Watch
- · Patent Landscape
- · Mechanism Cluster Map
- · Audio Briefing (5 min)